(Reuters) -AstraZeneca chief executive Pascal Soriot is considering moving the company’s stock market listing to the United States, The Times reported on Tuesday, citing multiple sources.
The company did not immediately respond to Reuters’ request for comment.
(Reporting by Aatrayee Chatterjee in Bengaluru; Editing by Leroy Leo)
Comments